Synthesis, structure characterization, and biological evaluation of some new 1,2,3-benzotriazole derivatives

Medicinal Chemistry Research

Volumn 19, Issue 8, 2010, Pages 970-983

  Wan, Jun ^a,b   Yan, Xia ^b   Ma, Cuiping ^b   Bi, Sai ^b   Zhu, Hai Liang ^a  

^a NANJING UNIVERSITY   (China)

^b QINGDAO UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Antimycotic activities; Antitumor activities; Benzotriazole compounds; Crystal structure

Indexed keywords

3 (1H BENZO[D][1,2,3]TRIAZOL 1 YL) 1 (2,4 DICHLOROPHENYL) 1 OXOPROPAN 2 YL ISONICOTINATE; 3 (1H BENZO[D][1,2,3]TRIAZOL 1 YL) 1 (2,4 DICHLOROPHENYL) 1 OXOPROPAN 2 YL NICOTINATE; 3 (1H BENZO[D][1,2,3]TRIAZOL 1 YL) 1 (2,5 DICHLOROPHENYL) 1 OXOPROPAN 2 YL NICOTINATE; 3 (1H BENZO[D][1,2,3]TRIAZOL 1 YL) 1 (4 CHLOROPHENYL) 1 OXOPROPAN 2 YL ISONICOTINATE; 3 (1H BENZO[D][1,2,3]TRIAZOL 1 YL) 1 (4 CHLOROPHENYL) 1 OXOPROPAN 2 YL NICOTINATE; 3 (1H BENZO[D][1,2,3]TRIAZOL 1 YL) 1 (4 METHOXYPHENYL) 1 OXOPROPAN 2 YL NICOTINATE; 3 (1H BENZO[D][1,2,3]TRIAZOL 1 YL) 1 OXO 1 PHENYLPROPAN 2 YL ISONICOTINATE; 3 (1H BENZO[D][1,2,3]TRIAZOL 1 YL) 1 OXO 1 PHENYLPROPAN 2 YL NICOTINATE; 3 (1H BENZO[D][1,2,3]TRIAZOL 1 YL) 1 OXO 1,4 TOLYLPROPAN 2 YL ISONICOTINATE; 3 (1H BENZO[D][1,2,3]TRIAZOL 1 YL) 1 OXO 1,4 TOLYLPROPAN 2 YL NICOTINATE; BENZOTRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; LIVER CANCER; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ANALYSIS;

EID: 78650725947     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-009-9243-3     Document Type: Article

References (29)

1. Abonia R, Insuastya B, Quirogaa J, Noguerasb M, Meierc H (2004) Use of β-(N,N-dialkylamino) propiophenones in the synthesis of nitrogenated heterocyclic compounds. Mini Rev Org Chem 1:387-402
2. Al-Soud YA, Al-Masoudi NA, Ferwanah A (2003) Synthesis and properties of new substituted 1,2,4- triazoles: potential antitumor agents. Bioorg Med Chem 11(8):1701-1708
3. Antonio C, Michele P, Gianpiero B, Bernardetta B, Marta M, Roberta L (2004) Synthesis and antiproliferative activity of 3-aryl-2-[1H(2H)- benzotriazol-1(2)-yl]acrylonitriles variously substituted: Part 4. Il Farmaco 59:637-644
4. Biagi G, Giorgi I, Livi O, Scartoni V, Barili PL, Calderone V (2001) New 5-substituted-1-(2- hydroxybenzoyl)-benzotriazoles, potassium channel activators IV. Il Farmaco 56:827-834
5. Cui YM, Nan FJ (2006) Biological electron emission principle of lead compounds in drug optimization. Chin Bull Life Sci 18:161
6. Emami S, Falahati M, Banifatemi A, Shafiee A (2004) Stereoselective synthesis and antifungal activity of (Z)-trans-3-azolyl-2-methylchromanone oxime ethers. Bioorg Med Chem 12:5881-5889
7. Fang L-Y, Zhang G-S, Li C-L, Zheng X-C, Zhu L-Z, Xiao J-J, Szakacs G, Nadas J, Chan K-K, Wang PG, Sun D-X (2006) Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance. J Med Chem 49:932-941
8. Hansen MB, Nielsen SE, Berg K (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203-210
9. Kasiotis KM, Haroutounian SA (2006) 2-Pyridin-2-yl-1H-indole derivatives: sSynthesis, estrogen receptor binding affinity, and photophysical properties. Bioorg Chem 34:1-14
10. Leonetti F, Favia A, Rao A, Aliano R, Paluszcak A, Hartmann RW, Carotti A (2004) Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors. J Med Chem 47:6792-6803
11. Lin R, Connolly PJ, Huang SL, Wetter SK, Lu YH, Murray WV, Emanuel SL, Gruninger RH, Fuentes- Pesquera AR, Rugg CA, Middleton SA, Jolliffe LK (2005) 1-Acyl-1H-[1,2,4]triazole-3,5-diamine analogues as novel and potent anticancer cyclin-dependent kinase inhibitors: synthesis and evaluation of biological activities. J Med Chem 48:4208-4211
12. McClure KF, Abramov YA, Laird ER, Barberia JT, Cai W, Carty TJ, Cortina SR, Danley DE, Dipesa AJ, Donahue KM, Dombroski MA, Elliott NC, Gabel CA, Han S, Hynes TR, LeMotte PK, Mansour MN, Marr ES, Letavic MA, Pandit J, Ripin DB, Sweeney FJ, Tan D, Tao Y (2005) Theoretical and experimental design of a typical kinase inhibitor: application to p38 MAP kinase. J Med Chem 48:5728-5737
13. Nardelli NJ (1995) PARST95-an update to PARST: a system of Fortran routines for calculating molecular structure parameters from the results of crystal structure analyses. Appl Crystallogr 28:659
14. Pagliai F, Pirali T, Grosso ED, Brisco RD, Tron GC, Sorba G, Genazzani AA (2006) Rapid synthesis of triazole-modified resveratrol analogues via click chemistry. J Med Chem 49:467-470
15. Saberi MR, Vinh TK, Yee SW, Griffiths BJN, Evans PJ, Simons C (2006) Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation. J Med Chem 49:1016-1022
16. Saüczewski F, Reszka P, Gdaniec M, Grünert R, Bednarski PJ (2004) Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles. J Med Chem 47:3438-3439
17. Scapin G, Patel SB, Becker JW, Wang Q, Desponts C, Waddleton D, Skorey K, Cromlish W, Bayly C, Therien M, Gauthier JY, Li CS, Lau CK, Ramachandran C, Kennedy BP, Asante-Appiah E (2003) The structural basis for the selectivity of benzotriazole inhibitors of PTP1B. Biochemistry 42:11451-11459
18. Semple G, Skinner PJ, Cherrier MC, Webb PJ, Sage CR, Tamura SY, Chen R, Richman JG, Connolly DT (2006) 1-Alkyl-benzotriazole-5-carboxylic acids are highly selective agonists of the human orphan G-protein-coupled receptor GPR109b. J Med Chem 49:1227-1230
19. Sheldrick GM (1996) SADABS program for empirical absorption correction of area detector data. University of Göttingen, Göttingen
20. Sheldrick GM (1997) SHELXTL V51 software reference manual. Bruker AXS, Madison, WI
21. Siemens (1996) SMART and SAINT area detector control and integration software. Siemens Analytical X-Ray Systems, Madison, WI
22. Spek AL (1990) PLATON, an integrated tool for the analysis of the results of a single crystal structure determination. Acta Crystallogr A 46:C34
23. Touami SM, Poon CC, Wender PA (1997) Sequence specific DNA cleavage by conjugates of benzotriazoles and minor groove binders. J Am Chem Soc 119:7611-7612
24. Wan J, Li CL, Li XM, Zhang SS (2006) Synthesis, structure and biological activities of 2-(1H-1,2,3- benzotriazol-1-yl)-1-(4-methylphenyl)-2-(1H-1, 2, 4-triazol-1-yl)-1-ethanone. Chem Res Chin Univ 22:465-467
25. Wang YQ, Li LF, Tian ZM, Jiang W, Larrick JW (2006) Synthesis and antitumor activity of CBI-bearing ester and carbamate prodrugs of CC-1065 analogue. Bioorg Med Chem 14:7854-7861
26. Wilson AJ (1992) International tables for X-ray crystallography. Vol C. Kluwer Academic, Dordrecht, Netherlands
27. Xu LZ, Jian FF, Gao HR, Chong CY (2003) Synthesis, structure and biological activities of S-[a-(4- methoxyphenylcarbonyl)-2-(1,2,4-triazole-1-yl) ] ethyl-N,N-dimethyldithiocarbamate. Chin J Chem 21:1615-1617
28. Zhang SS, Wan J, Li CL, Li M, Qu B (2007a) Syntheses and biological activities of novel triazole compounds. J Heterocycl Chem 44:75-78
29. Zhang SS, Wan J, Li XM, Li CL, Xu LZ (2007b) Syntheses, structure and biological activities of 2-(1Hbenzo[ 1,2,3]triazole-1-y1)-1-(3-methyl-4- bromobipheny1)-2-(1H-1,2,4-triazole-1-y1)ethanon. Chem Res Chin Univ 23:120-122